BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10791030)

  • 21. CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets.
    Israels SJ; McMillan-Ward EM; Easton J; Robertson C; McNicol A
    Thromb Haemost; 2001 Jan; 85(1):134-41. PubMed ID: 11204565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
    Shido K; Ahmad G; Hsu L; Kamiyama M
    J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycoprotein Ia-IIa (VLA-2) and glycoprotein Ib-IX complexes are processed independently during thrombin-induced platelet activation.
    Nurden P; Bihour C; Combrie R; Gralnick H; Nurden AT
    J Lab Clin Med; 1994 Oct; 124(4):579-88. PubMed ID: 7930882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of GP IIb/IIIa receptors during platelet activation: influence on efficacy of receptor blockade.
    Matzdorff A; Voss R
    Thromb Res; 2006; 117(3):307-14. PubMed ID: 15894353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of shear stress on expression of platelet membrane glycoproteins].
    Li M; Cong Y; Deng X; Hu J; Qin X
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):267-70. PubMed ID: 11953177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet membrane fluidity in Alzheimer's disease and multi-infarct dementia: a spin label study.
    Kaakkola S; Rosenberg PH; Alila A; Erkinjuntti T; Sulkava R; Palo J
    Acta Neurol Scand; 1991 Jul; 84(1):18-21. PubMed ID: 1656688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass.
    Rinder CS; Mathew JP; Rinder HM; Bonan J; Ault KA; Smith BR
    Anesthesiology; 1991 Oct; 75(4):563-70. PubMed ID: 1718190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients.
    Stellos K; Panagiota V; Kögel A; Leyhe T; Gawaz M; Laske C
    J Cereb Blood Flow Metab; 2010 Nov; 30(11):1817-20. PubMed ID: 20717123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet membrane fluidity in Alzheimer's disease and major depression.
    Zubenko GS; Cohen BM; Reynolds CF; Boller F; Malinakova I; Keefe N
    Am J Psychiatry; 1987 Jul; 144(7):860-8. PubMed ID: 3605398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 years.
    Zubenko GS; Teply I; Winwood E; Huff FJ; Moossy J; Sunderland T; Martinez AJ
    Am J Psychiatry; 1996 Mar; 153(3):420-3. PubMed ID: 8610834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminium on platelet and erythrocyte membranes.
    van Rensburg SJ; Carstens ME; Potocnik FC; Aucamp AK; Taljaard JJ; Koch KR
    Neurochem Res; 1992 Aug; 17(8):825-9. PubMed ID: 1641066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular membranes are more fluid in platelets of Alzheimer's disease patients.
    Piletz JE; Sarasua M; Whitehouse P; Chotani M
    Neurobiol Aging; 1991; 12(5):401-6. PubMed ID: 1770973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid peroxidation and platelet membrane fluidity--implications for Alzheimer's disease?
    van Rensburg SJ; Daniels WM; van Zyl J; Potocnik FC; van der Walt BJ; Taljaard JJ
    Neuroreport; 1994 Nov; 5(17):2221-4. PubMed ID: 7881031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of feiliuping No. 2 on platelet surface glycoprotein expression in mid-late stage lung cancer patients].
    Zhang P; Piao B; Sun G
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jan; 20(1):31-3. PubMed ID: 11783333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet membrane fluidity and plasma malondialdehyde levels in Alzheimer's demented patients with and without family history of dementia.
    Kálmán J; Dey I; Ilona SV; Matkovics B; Brown D; Janka Z; Farkas T; Joó F
    Biol Psychiatry; 1994 Feb; 35(3):190-4. PubMed ID: 8173019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroencephalographic correlates of increased platelet membrane fluidity in Alzheimer's disease.
    Zubenko GS; Brenner RP; Teply I
    Arch Neurol; 1988 Sep; 45(9):1009-13. PubMed ID: 3415519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Family study of platelet membrane fluidity in Alzheimer's disease.
    Zubenko GS; Wusylko M; Cohen BM; Boller F; Teply I
    Science; 1987 Oct; 238(4826):539-42. PubMed ID: 3659926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological correlates of clinical heterogeneity in primary dementia.
    Zubenko GS
    Neuropsychopharmacology; 1992 Feb; 6(2):77-93. PubMed ID: 1610488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.